Quantcast

Latest Bioethics Stories

2014-02-03 04:22:20

COLOGNE, Germany, February 3, 2014 /PRNewswire/ -- Highly-effective unknown doping agents have emerged; cannot be tested A few days before the opening of the Winter Olympics in Sochi, WDR research has revealed serious doubts about a credible anti-doping campaign in the Olympics' host country. In the ARD Sports Show (ARD, today, February 2, 2014, 18:00) and the WDR broadcast "Sport Inside" (WDR evening, February 3, 2014, 22:55), WDR reporters cover encounters of a...

2014-01-29 16:28:39

Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 29, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the completion of the randomized, double-blind placebo-controlled Phase 2 study of KB003, its anti-GM-CSF monoclonal antibody (mAb), in patients with severe asthma. While the study showed that KB003 was generally safe and well tolerated, it did not meet its primary clinical endpoint of improvement in FEV(1) (a measurement of pulmonary...

2014-01-29 00:21:07

UEP / HSUS Proposal Would Preempt State Laws and Keep Hens in Cages SAN FRANCISCO, Jan. 28, 2014 /PRNewswire-USNewswire/ -- The Humane Farming Association and a broad coalition of animal organizations are celebrating a victory as the United Egg Producers (UEP) and the Humane Society of the United States (HSUS) failed to insert Senator Dianne Feinstein's controversial "Egg Products Inspection Act Amendments" (S. 820) into the Farm Bill. Referred to by many as the Rotten Egg Bill,...

2014-01-24 23:21:39

Natreon, Inc, and NutraGenesis, LLC are pleased to announce a new study published on Sensoril® demonstrates Sensoril’s ability to significantly improve cognitive and psychomotor performance. Brattleboro, VT (PRWEB) January 24, 2014 Natreon, Inc, and NutraGenesis, LLC are pleased to announce publication of a new study on Sensoril® which demonstrated Sensoril’s ability to significantly improve cognitive and psychomotor performance during simple reaction, choice discrimination,...

2014-01-23 04:21:19

LONDON, January 23, 2014 /PRNewswire/ -- The recent BBC report on January 3rd revealed shocking figures of obesity quadrupling to nearly one billion in the developing world since the 1980s. 64% of adults are now classified as overweight or obese in the UK. With high levels of cheap convenience food available, and the increasing numbers of overweight Brits on the increase, Weightmasters have revealed successful results from clinical trials on their Natural Appetite Suppressant,...

2014-01-22 23:23:03

Xtalks presents an exciting live webinar on Thursday, February 13, 2014 at 11:00am EST (16:00 GMT). Join keynote speakers Aysha Akhtar, Fellow, Oxford Centre for Animal Ethics, and Medical Officer, Food and Drug Administration, and Dr. Toby Gill, Independent Nanotechnology Professional, UK, for a one-hour discussion on alternatives to animal testing methods. Toronto, Canada (PRWEB) January 22, 2014 The presenters will discuss scientific and ethical imperatives associated with the use of...

2014-01-20 23:04:09

GIA announces the release of a trend report on Designer Babies. The concept of Designer Babies is gaining in popularity driven by developments in genetic engineering that help scientists to screen embryos for genetic disorders to artificially make babies with desired personal and genetic traits. San Jose, California (PRWEB) January 20, 2014 Follow us on LinkedIn – Designer babies are defined as babies with artificial genetic makeup selected through a combination of genetic engineering...

2014-01-17 12:25:10

WASHINGTON, Jan. 17, 2014 /PRNewswire-USNewswire/ -- As you line up interviews and segments for Life News this month, Americans United for Life President and CEO Dr. Charmaine Yoest, along with other members of AUL's legal and political team, are the right choice for analysis and insight into the most current trends related to abortion's 40-plus year legacy and impact. Today in Rolling Stone, AUL and Dr. Yoest were featured in an in-depth story on the legislative strategy that is...

2014-01-16 08:26:49

Receipt of Proceeds increases January Cash Position to Approximately $6.6 million PRINCETON, N.J., Jan. 16, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well a developing several biodefense vaccines and therapeutics, announced today that it has recently received approximately $750,000, net of...

2014-01-09 16:25:37

OPEN-LABEL EXTENSION SHOWS A FAVORABLE SAFETY PROFILE AND DYSKINESIA REDUCTION THROUGH 12 WEEKS OF DOSING SAN DIEGO, Jan. 9, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-98854, a small molecule VMAT2 inhibitor, in development for tardive dyskinesia, showed an excellent safety profile and a clinically meaningful reduction in tardive dyskinesia symptoms in up to twelve weeks of continuous dosing. This is the second study reporting out this...


Latest Bioethics Reference Libraries

OncoMouse
2013-10-02 09:29:43

The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...

More Articles (1 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related